Hematology Oncology Associates, PC

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Follicular lymphoma
• Mantle cell lymphoma

Closed trials

• Completed

  Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.

  NCT01996865· Phase 3· Celgene· Source